David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 32,000 shares at $2.85 ($91K) on 2012-12-19, disclosed to the SEC on 2012-12-21.
Open-market purchase of $91k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 12,000 | $34K | 37.5% |
| 2 | $2.85 | 20,000 | $57K | 62.5% |
| Total | $2.85 avg | 32,000 | $91K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |